Ultralife Q4 revenue $23.8M, operating loss $1.2M; supply chain delays impacted results

ULTRALIFE CORP

2021-FY EPS reported -$0.01 revenue$98,267,000

GAAP net loss $1.1M ($0.07 loss per share) vs net income $2.1M ($0.13 EPS) in Q4 2020.
Revenue down 18% to $23.8M; delayed shipments from supply chain issues reduced revenue by ~$5.4M.
Backlog grew 35% core YoY to >$53M; over $63M including Excell acquisition.
FY2021 GAAP EPS ($0.01), Adjusted EPS ($0.02) vs FY2020 GAAP EPS $0.33, Adjusted EPS $0.41.
Acquisition of Excell Battery Group in Dec 2021 added initial revenue but also $0.5M in one-time expenses and purchase accounting adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.